Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey

Patients with rheumatic and musculoskeletal (RMD) diseases may be at higher risks for COVID-19 infection. Data on the safety of the adenoviral vector-borne ChAdOx1 nCoV-19 and the heat-inactivated BBV152 Vaccines in this group are limited. 724 patients with RMD who had received at least one dose of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherian, Somy, Paul, Aby, Ahmed, Sakir, Alias, Bazil, Manoj, Manesh, Santhosh, Ansu K., Varghese, Delcey Rachel, Krishnan, Narayanan, Shenoy, Padmanabha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Observational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211311/
https://www.ncbi.nlm.nih.gov/pubmed/34142203
http://dx.doi.org/10.1007/s00296-021-04917-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211311/
https://www.ncbi.nlm.nih.gov/pubmed/34142203
http://dx.doi.org/10.1007/s00296-021-04917-0

Ejemplares similares